All News about Larimar Therapeutics Inc
![](https://cdn.benzinga.com/files/images/story/2022/08/12/m-zzoa5g8hspi-unsplash.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/12/image_1.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/11/bz-pharma_6.jpg?width=1200&height=800&fit=crop)
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 11, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14619.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13860.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_12423.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/09/image_3.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13560.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/05/image_3.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/01/image39.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_2795.jpeg)
![](https://mms.businesswire.com/media/20220217005050/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_2709.jpeg)
![](https://mms.businesswire.com/media/20220216005533/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_393.png)
![](https://cdn.benzinga.com/files/images/story/2012/mid-afternoon-market-update_130.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/mid-day-market-update_130.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_121.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_2642.jpeg)
![](https://cdn.benzinga.com/files/images/story/2012/mid-morning-market-update_129.jpg?width=1200&height=800&fit=crop)
![](https://cms.zerohedge.com/s3/files/inline-images/ES%202022-02-15_7-02-19_0.jpg?itok=V0Lr1fDI)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/analyst_ratings_image_2667.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/test-gcd00d1810_1280_0.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3500.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_554.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_379.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-afternoon-market-update_30.jpg)
Mid-Afternoon Market Update: Nasdaq Down 1%; Protagonist Therapeutics Shares Plummet
September 17, 2021
Via Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.